Renal insufficiency was correlated with 2-year mortality for rural female patients with ST-segment elevation acute myocardial infarction after reperfusion therapy: a multicenter, prospective study

Table 2 Outcomes of patients according to eGFR group

	Normal group	Moderate group	RI group	χ ²	p value
	(n = 233)	(n = 108)	(n = 95)	χ ²	p value
In hospital
MACE	7 (3.00)	6 (5.56)	10 (10.53)^a	7.664	0.022
death	4 (1.72)	4 (3.70)	7 (7.37)^a	6.127	0.045
Recurrent MI	2 (0.86)	1 (0.93)	1 (1.05)	0.472	1
TVR	0	1 (0.93)	1 (1.05)	2.941	0.216
Stroke	0	0	0		NS
Bleeding	1 (0.43)	0	1 (1.05)	1.403	0.45
CIN	0	1 (0.93)	2 (2.11)	4.383	0.06
At 1-year follow-up
MACE	35 (15.02)	24 (22.22)	36 (37.89)^ab	20.734	<0.001
death	10 (4.29)	8 (7.41)	16 (16.84)^a	14.814	<0.001
Recurrent MI	9 (3.86)	4 (3.70)	3 (3.16)	0.117	1
TVR	12 (5.15)	9 (8.33)	12 (12.63)	5.519	0.063
Stroke	1 (0.43)	2 (1.85)	1 (1.05)	2.02	0.424
Bleeding	3 (1.29)	1 (0.93)	4 (4.21)	3.244	0.173
At 2-year follow-up
MACE	52 (22.32)	39 (36.11)^a	50 (52.63)^a	29.275	<0.001
death	16 (6.87)	11 (10.19)	23 (24.21)^ab	20.227	<0.001
Recurrent MI	13 (5.58)	10 (9.26)	6 (6.32)	1.631	0.442
TVR	17 (7.30)	12 (11.11)	13 (13.68)	3.524	0.172
Stroke	3 (1.29)	3 (2.78)	3 (3.16)	1.919	0.391
Bleeding	3 (1.29)	3 (2.78)	5 (5.26)	4.275	0.109

eGFR estimated glomerular filtration rate, MI myocardial infarction, TVR target vessel revascularization, MACE major adverse cardiac events
^acompared to Normal group, p < 0.05
^bcompared to Moderate group, p < 0.05

ISSN: 1471-2261